Cancer
Researchers from Chuo University in Tokyo, Japan, have made a significant breakthrough in cancer gene therapy by developing micro/nano motors that can deliver targeted drugs to cancer cells. These self-propelled micro motors, functionalized with doxorubicin-loaded liposomes, can be triggered to release the drug upon near-infrared irradiation, leading to efficient
Cancer
Scientists at First Affiliated Hospital of Soochow University have made significant progress in understanding the mechanisms underlying gastric cancer peritoneal metastasis (GCPM). According to a study published in Cell Death and Disease, researchers found that mesothelial-mesenchymal transition (MMT) plays a crucial role in the progression of GCPM. The study identified
Cancer
Researchers at Mayo Clinic, in collaboration with healthcare professionals, have made significant progress in developing an Enhanced Electronic Health Record (EHR)-facilitated cancer symptom control approach. The Enhanced EHR-facilitated Cancer Symptom Control (E2C2) Trial, a pragmatic trial, was designed to test a collaborative care approach for managing common cancer symptoms.
Cancer
New research from Anhui Agricultural University, published in International Immunopharmacology, has shed light on the potential of nanovaccines in combating infectious diseases and cancer. The study, led by researchers Khadija Raziq and Ting Xue, with co-author Dongdong Sun, explores the use of nanovaccines in combinatory immune regulation therapies. According to
Cancer
Researchers have made significant strides in understanding the role of macropinocytosis in cancer development and treatment, opening doors to innovative approaches in personalized medicine. A study published in the Journal of Controlled Release highlights the importance of modulating macropinocytosis in cancer therapy, offering new opportunities for effective and targeted treatments.
Cancer
Researchers at the Fourth Affiliated Hospital of Harbin Medical University have made a significant discovery in the field of nanotechnology, designing a novel polysaccharide-based fluorescent nanocarrier system, HPMC-AuNPs@1, for the delivery of plant extract compound 1. This nanocarrier system has shown great promise in detecting carcinoembryonic antigen (CEA) and
Cancer
Researchers from BioMarin Pharmaceutical Inc. have presented a molecular characterization of adeno-associated virus (AAV) integration profiles in human biopsy samples from valoctocogene roxaparvovec clinical trials and nonhuman primates (NHPs) treated with the same gene therapy. The study aimed to assess the integration profiles of the AAV vector, which is used
Cancer
Researchers from Hamadan University have made significant progress in the field of oncology, utilizing nanomedicine to enhance cancer detection at early stages. By leveraging the properties of superparamagnetic iron oxide nanoparticles (SPIONs) and ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs), scientists have developed a novel approach to molecular imaging, which can
Cancer
Researchers from Fujian Medical University have discovered a promising approach to improving the effectiveness of chimeric antigen receptor (CAR) T-cell therapy for solid tumors. The study, published in the Journal of Translational Medicine, suggests that biomimic nanoenzymes can be used to enhance CAR-T cell infiltration and efficacy by addressing vascular
Cancer
Researchers are investigating gamma delta T cell cancer therapy, a unique type of immunotherapy that uses a subset of T cells to recognize and destroy cancer cells. Unlike conventional immune therapies, gamma delta T cells can detect and target a wide variety of tumor types, including those not targeted by
Cancer
The CAR T cell therapy landscape has undergone significant transformations in the past decade, with multiple FDA-approved products now available for various B-cell malignancies. The current approvals include distinct products for large B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, chronic lymphocytic lymphoma, and acute lymphoblastic lymphoma. These therapies demonstrate remarkable
Cancer
Research conducted at the University of Science and Technology of China has revealed significant advancements in cancer gene therapy using adeno-associated virus (AAV) vectors. AAV vectors have been recognized as a safe and effective method for delivering therapeutic transgenes, with four AAV-based gene therapy drugs already approved by the US
